Clinical Outcomes After EMR or ESD of Colorectal Neoplasms - A Multicenter Registry
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorChinese University of Hong Kong
About this trial
This study aims to establish a multicenter registry platform to capture clinical data from subjects undergoing colorectal EMR and ESD.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subjects who undergo EMR or ESD for colorectal lesions.
Disqualifiers
Not applicable.
Trial population
Subjects who undergo EMR or ESD for colorectal lesions.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
EMR or ESD
Other interventionEndoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are two main endoscopic treatment options for colorectal neoplasms
Treatment groups
2,500 Participants
are divided into 1 treatment groupGroup A: Subjects who undergo EMR or ESD1 intervention
Trial outcomes
Primary outcomes
1
Curative resection rate of EMR or ESD for colorectal neoplasms
The short- and long-term clinical efficacy outcomes of colorectal EMR or ESD
Time frame
10 years2
Adverse event rate of EMR or ESD for colorectal neoplasms
The short- and long-term clinical safety outcomes of colorectal EMR or ESD
Time frame
10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: